{"version":1,"type":"rich","provider_name":"Libsyn","provider_url":"https:\/\/www.libsyn.com","height":90,"width":600,"title":"S3 E4 \u2013 \u201cNo \u2018One Type Fits All\u2019 in Lung Cancer Treatment\u201d: An Interview with Dr Anne-Marie Baird (Lung Cancer Europe)","description":"For this episode of Karger\u2019s The Waiting Room Podcast, we spoke again with Dr Anne-Marie Baird, who currently serves as the president of&amp;nbsp;Lung Cancer Europe&amp;nbsp;(LuCE). She is a Senior Research Fellow at Trinity College Dublin, Ireland, and a patient advocate. In this episode we are going to focus on non-small cell lung cancer, genetic predisposition, biomarkers and treatment. More information on lung cancer is freely available here:  Fast Facts for Patients: Non-small Cell Lung Cancer with KRAS Mutation Infographic Summary Sheets for Patients:  KRAS G12C in Metastatic Non-Small Cell Lung Cancer When Checkpoint Inhibitor Therapy Stops Working Biomarkers in Metastatic Non-Small Cell Lung Cancer  \u201cAnyone with Lungs Can Get Lung Cancer\u201d: An Interview with Dr Anne-Marie Baird (Lung Cancer Europe)  &amp;nbsp; For more podcast episodes from Karger please visit https:\/\/www.karger.com\/pages\/podcasts. ","author_name":"Karger - The Waiting Room","author_url":"https:\/\/sites.libsyn.com\/399557","html":"<iframe title=\"Libsyn Player\" style=\"border: none\" src=\"\/\/html5-player.libsyn.com\/embed\/episode\/id\/27001749\/height\/90\/theme\/custom\/thumbnail\/yes\/direction\/forward\/render-playlist\/no\/custom-color\/88AA3C\/\" height=\"90\" width=\"600\" scrolling=\"no\"  allowfullscreen webkitallowfullscreen mozallowfullscreen oallowfullscreen msallowfullscreen><\/iframe>","thumbnail_url":"https:\/\/assets.libsyn.com\/secure\/content\/139985154"}